MMRGlobal Patents Drive Revenue Through First Interbit Data Hospital Installation

LOS ANGELES, CA and NATICK, MA--(Marketwire - Feb 4, 2013) - MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary MyMedicalRecords, Inc. (MMR), and Interbit Data (Interbit), strategic partner and Licensee, today announced that Sturgis Hospital in Michigan, a 5-Star Acute-Care hospital, has gone live with MyMedicalRecords Personal Health Record (PHR) and patient portal (www.mmrpatientvideos.com). According to Bob Lorsch, MMRGlobal CEO, "After spending millions of dollars around the world on patent prosecution, MMR is successfully signing license agreements that are generating revenue."

The PHR, whose use is certified for Meaningful Use well in advance of Stage 2 requirements, is the first of its kind to be designed, built and installed by Interbit using its NetDelivery secure solution. The service is being delivered pursuant to a patent license agreement between MyMedicalRecords, Inc. and Interbit Data that carries with it rights to IP contained in seven MMR U.S. patents with nearly 400 claims pertaining to the access and provisioning of Personal Health Records, Electronic Health Records and other MMR IP bundled with NetDelivery for Interbit clients. MMR's international patent portfolio includes Australia, New Zealand, Singapore, Mexico, Canada, Europe, Israel, South Korea and Japan in addition to the U.S. (http://michaelbass.com/PDF/Patent_Valuation.pdf)

Arthur Young, President of Interbit, said, "Our Interbit-MMR solution is the first of its kind that results in patients having an untethered PHR which seamlessly integrates with a hospital's MEDITECH EMR system as well as with any other healthcare professional anywhere in the world. We are very excited by the ability we have created for the hospital staff to effortlessly send the patient's data to the MMR portal, and, more than just meeting Meaningful Use requirements, begins to facilitate patients' ability to manage and control their own health information."

Lorsch added, "The Interbit-MMR solution allows patients to have immediate access to their medical records to share them with their primary care physician and specialists after discharge from the hospital, which streamlines care, reducing medical costs and exposure to readmissions." The system integrates Interbit's NetDelivery application with MMR's MMRPatientView patient portal and the MyMedicalRecords Personal Health Record offering a secure solution to provide access to a patient's protected health information. Interbit NetDelivery solutions are installed in 750 EMR hospital sites. The joint solution allows hospitals to seamlessly and securely provide patients with the ability to access and share their protected health information as it was created in the hospital's EMR system for access and review by patients, authorized family members, caretakers and designated healthcare professionals.

In addition to the MyMedicalRecords PHR and MMRPatientView portal, MMR is a leading provider of MyEsafeDepositBox storage solutions and MMRPro document management and imaging systems for healthcare professionals. Interbit Data is a leading provider of software and services connecting people with information for more efficient healthcare. Interbit and MMR will be demonstrating their integrated solution in MMRGlobal Booth #3363 at the 2013 HIMSS Annual Conference and Exhibition in New Orleans which runs March 3-7 (www.himssconference.org).

Each MyMedicalRecords PHR is currently upgradable to cover up to 10 family members, including veterinary records for the family's pets. In addition, MMR's platform offers numerous health management tools, including the ability to schedule and generate alerts about upcoming doctor appointments and prescription refills, an updatable family history of conditions, surgeries and allergies, and an automated drug interaction tool that checks for adverse interactions between over 20,000 prescription and over-the-counter drugs.

About MMRGlobal
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of the Company's products and services at www.mmrtheater.com.

About Interbit Data
Founded in 1997 and named to the 2009, 2010, and 2011 Inc. 5000 list of America's fastest-growing companies, Interbit Data helps healthcare organizations deliver better, more consistent patient care with secure, reliable and cost-effective software solutions that improve operational efficiency. The company's information distribution products deliver information securely over the Internet in multiple formats, such as fax, print, email, encrypted file or HL7 message format, and integrate it easily into physicians' practice EMRs. Interbit Data's business continuance products give healthcare providers continuous access to patient data in the event of a network or system outage. Interbit Data products are used by more than 750 customers worldwide. For more information about Interbit Data and its NetSolutions products, visit www.interbitdata.com.

Forward-Looking Statements
All statements in this press release that are not strictly historical in nature, whether or not such statement relates directly to the Patent License Agreement with Interbit Data, and including, without limitation, intellectual property licenses, potential intellectual property enforcement actions, infringement claims or litigation, and future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "potential," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Actual outcomes and results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to: unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop, monetize and protect our patent portfolio for both the Company's health IT and biotechnology intellectual property assets in the U.S. and internationally; the timing of milestone payments in connection with licensing our intellectual property; our ability to establish and maintain strategic relationships; changes in our relationships with our licensees; the risk the Company's products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; the timing and volume of sales and installations; the length of sales cycles and the installation process; the market's acceptance of new product and service introductions; competitive product offerings and promotions; changes in government laws and regulations including the 2009 HITECH Act and changes in Meaningful Use and the 2010 Affordable Care Act; future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; the possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; other litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission including disclosures about the Company's relationship with the Michael Bass Group since 2009. The Company is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.